Centrus and Oklo Forge Nuclear Supply Chain Loop, Raising Stakes on Ohio Energy Hub

The investment case for both Centrus and Oklo hinges on a single, high-conviction thesis: the creation of a vertically integrated domestic nuclear hub in southern Ohio. This is not a speculative bet on future technology, but a coordinated, multi-billion dollar build-out with specific milestones and partners. The financial blueprint is clear, but the execution path is steep.

Centrus is moving into full-scale construction. The company has formalized a strategic collaboration with Fluor as its Engineering, Procurement and Construction (EPC) contractor for its multi-billion-dollar expansion of its uranium enrichment capacity in Piketon, Ohio. This partnership, announced in February, signals a transition from planning to deployment. With centrifuge manufacturing already underway, the company is moving full-speed ahead and has begun pre-construction activities in 2026. Fluor's involvement brings critical expertise for managing complex nuclear build-outs, de-risking a key phase of the project.

Oklo's counterpart is a massive power campus. The company has announced an agreement with Meta to advance its plans for a 1.2 GW power campus in Pike County, Ohio. This project is backed by a prepayment from Meta, providing crucial early-stage funding and project certainty. The development is designed to scale incrementally, with Phase 1 targeting first power in 2030 and the full 1.2 GW capacity by 2034. This timeline aligns with the projected growth of data center demand in the region.

The strategic partnership formalizes the hub. In a new Memorandum of Understanding, Centrus and Oklo have agreed to a closed-loop supply chain. Oklo would purchase HALEU from Centrus's production facility in Piketon, the only such facility licensed by the NRC. Centrus would purchase electricity from Oklo's planned Ohio plants to power its own HALEU production. This creates a powerful, integrated ecosystem where one company's output fuels the other's operations, enhancing both supply chain security and economic viability.

The bottom line is a coordinated development that offers a compelling structural thesis. This partnership aims to establish southern Ohio as a critical national hub for advanced nuclear fuel and power. For institutional investors, the setup presents a conviction buy on the long-term energy transition and supply chain reshoring. Yet the investment case demands a high tolerance for execution risk and capital intensity. The multi-year, multi-billion dollar build-out for both companies, reliant on complex partnerships and regulatory approvals, represents a significant capital commitment with a long payoff horizon. The financial blueprint is sound, but the path to realizing it is a marathon, not a sprint.

Capital Allocation and Financial Resilience: Dry Powder vs. Premium Valuation

The financial capacity to fund these ambitious projects is a critical filter for institutional capital. Both companies possess substantial cash reserves, but their risk-adjusted return profiles diverge sharply.

Centrus enters this build-out with a fortress balance sheet. As of September 30, 2025, the company reported approximately $1.6 billion in unrestricted cash and marketable securities. This dry powder provides a significant margin of safety for its multi-billion-dollar expansion. Yet the financial model carries a structural vulnerability. The company's core Low-Enriched Uranium (LEU) segment faces a clear inflection point, as impending government policy changes will halt LEU sourcing from Russia by 2028. This creates a potential revenue cliff for that legacy business, making the successful ramp of its new HALEU production and the technical solutions contracts all the more critical for sustaining cash flow.

Oklo's financial position is more precarious in the near term. Its ~$1.2 billion in cash and marketable securities is sufficient to fund its first-of-a-kind (FOAK) Aurora project through its initial phases, but it funds a longer timeline. The market's valuation, however, reflects extreme optimism. As of early March, Oklo's stock trades at a 840% premium to its Morningstar fair value. This valuation embeds near-perfect execution for years to come, leaving little room for error or delay. For institutional investors, this presents a classic trade-off: deep-pocketed funding for a transformative project versus a valuation that demands flawless delivery.

The mutual supply agreement between the two companies materially improves the risk profile for both. For Oklo, securing a long-term offtake of HALEU from Centrus's licensed facility reduces fuel cost uncertainty and provides supply chain security for its power plants. For Centrus, the agreement creates a guaranteed, long-term customer for its HALEU output, de-risking a key revenue stream. This closed-loop partnership transforms a speculative supply chain into a contracted, integrated business model, enhancing the project's financial viability for both parties.

The bottom line for portfolio construction is a high-conviction, high-risk allocation. Centrus offers a quality factor play with strong financials but faces a known revenue transition. Oklo presents a pure-play bet on execution, funded by cash but priced for perfection. The mutual supply deal mitigates some of the core risks, but the ultimate return depends on the successful, on-budget delivery of multi-billion dollar, first-of-a-kind projects over a decade. For institutional capital, this is a conviction buy on the structural thesis, but one that requires a high tolerance for execution risk and a long time horizon.

Sector Rotation and Portfolio Construction: Quality Factor and Risk Premium

The Ohio nuclear hub exemplifies a powerful institutional theme: a sector rotation toward domestic energy security and carbon-free baseload power. This is not a fleeting trend but a structural tailwind driven by national policy, supply chain reshoring, and the insatiable power demand from AI. For portfolio construction, this creates a clear allocation opportunity, but one that requires careful segmentation between quality and speculation.

Centrus represents the quality factor within this thesis. The company possesses a critical, non-replicable asset: the only U.S. license to sell Low-Enriched Uranium (LEU) to commercial utilities. This government-backed monopoly, combined with its $900 million Department of Energy task order for HALEU expansion, provides a tangible, contracted revenue stream. Its financial resilience, with $1.6 billion in cash, further cements its status as a high-quality, capital-light play on the energy transition. Yet its stock's volatility, as seen in its 7,200% surge over the past decade, reflects its deep policy dependency. The upcoming halt to Russian LEU sourcing by 2028 is a known catalyst, but also a source of uncertainty. For institutional capital, Centrus is a core holding-a conviction buy on the quality factor of supply chain control and government contracts.

Oklo, by contrast, is a pure-play on advanced reactor deployment and embodies the required risk premium. Its 305% share price increase over the past year is a direct reflection of market optimism for its first-of-a-kind (FOAK) technology. The project's scale, with a 1.2 GW power campus and a prepayment from Meta, provides early-stage funding certainty. However, the company's financial model is built on flawless execution over a decade-long timeline. The analyst consensus of a "Buy" rating masks significant execution risk, as noted in the concerns over capital overages and scheduling delays. This is a speculative overweight, where the valuation demands perfection. The mutual supply agreement with Centrus mitigates some fuel cost uncertainty, but it does not eliminate the core FOAK construction risk.

The bottom line for portfolio construction is a dual mandate. The Ohio hub offers a compelling setup to overweight the nuclear sector, but the allocation must be split. A core position in Centrus provides exposure to the quality factor of a secured fuel supply chain. A smaller, tactical allocation to Oklo captures the growth premium of advanced reactor deployment, but only for capital with a high tolerance for execution risk and a long time horizon. The partnership between the two companies de-risks the ecosystem, but the individual stock risks remain distinct. For institutional investors, this is a classic portfolio construction play: blend a high-quality, policy-driven anchor with a high-risk, high-reward speculative bet, ensuring the overall portfolio is positioned for the structural shift toward domestic nuclear power.

Catalysts, Execution Risks, and Institutional Watchpoints

The Ohio nuclear hub thesis now enters its validation phase, where institutional capital will scrutinize near-term milestones against the backdrop of significant execution risks. For investors, the path forward is defined by a series of clear catalysts and a set of well-known vulnerabilities.

The primary near-term catalyst for Centrus is the disbursement of its $900 million Department of Energy task order for HALEU expansion. This federal funding is not just a cash infusion; it is a critical validation of the project's national security importance and a direct enabler for the company's multi-billion dollar Piketon expansion. The successful use of these funds to accelerate construction and centrifuge manufacturing will be a key indicator of operational momentum. For Oklo, the major catalyst is the submission and subsequent review of its NRC license application for its Aurora reactor. This regulatory milestone is the gateway to construction and will be watched closely for any signs of delay or additional requirements that could impact the project's 2030 first-power timeline.

Execution risks, however, remain substantial and are the primary filter for capital allocation. For Oklo, the core risk is the classic first-of-a-kind (FOAK) challenge: capital overages or scheduling delays on its Aurora project. Given the company's 305% share price increase over the past year, the market has priced in near-perfect execution. Any significant overrun or delay would directly threaten its internal rate of return and credibility, potentially accelerating cash burn. Centrus faces a different but equally critical risk: the impending government policy changes that will halt LEU sourcing from Russia by 2028. While the HALEU expansion is a strategic pivot, the company's legacy LEU segment is its current cash cow. A sharper-than-expected decline in that revenue stream before the new capacity ramps could pressure near-term financials, despite its strong cash position.

Regulatory hurdles compound these project-specific risks. Both companies operate in a highly regulated environment. For Centrus, this means ongoing oversight of its licensed HALEU facility and any new LEU production. For Oklo, it means the NRC's review process for its Aurora reactor and the broader licensing pathway for its technology. Any unexpected regulatory friction could introduce delays and cost uncertainty.

For institutional investors, the watchpoints are clear. Monitor quarterly progress updates on Centrus's HALEU production timeline and Oklo's construction milestones for signs of schedule adherence. Track changes in federal funding announcements that could impact project economics. And keep a close eye on the status of AEP's proposed nuclear ownership legislation in Ohio. While a long-term development, this potential shift in utility ownership rules could reshape the regional power market and the economics of new nuclear build-out, representing a structural policy catalyst or a source of future regulatory complexity.

The bottom line is that the Ohio hub thesis is now a test of execution. The catalysts are in place, but the risks are tangible. For institutional capital, this phase demands a disciplined, milestone-driven approach, where each update is weighed against the substantial risks of cost overruns, regulatory delays, and the known revenue transition for Centrus.